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Apical ballooning syndrome (ABS) is a unique reversible cardiomyopathy that is 
frequently precipitated by emotional or physical stress. In addition, the few drugs 
reported to precipitate ABS were either illegal or strictly controlled for medical 
use. This paper reports a case of ABS precipitated by a dietary supplement. Our 
case accentuates the potential risk of dietary supplements containing synephrine, 
which is uncontrolled and available to the general public. Therefore, the Korea 
Food and Drug Administration should regulate these dietary supplements, and 
warn healthcare workers and the general public of the potential hazards of the in-
discriminate abuse of dietary supplements.
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INTRODUCTION
Apical ballooning syndrome (ABS), also called stress-
induced cardiomyopathy or Takotsubo cardiomyopa-
thy, is characterized by transient akinesis from the 
apical to midventricular segments and hyperkinesis 
of the basal segments, with markedly reduced left 
ventricular systolic function [1]. ABS mimics acute 
coronary syndrome, since electrocardiography often 
reveals ST-segment elevation with mild elevation of 
cardiac biomarkers [2]. Generally, ABS is triggered by 
severe emotional or physical stress [3,4]. In addition, 
some drugs can precipitate the development of ABS. 
However, the drugs reported to trigger ABS were ei-
ther illegal or strictly controlled for medical use [5,6]. 
By contrast, this paper reports a case of ABS precipi-
tated by dietary supplements, which are not controlled 
and available to the general public.
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CASE REPORT
A 21-year-old female presented to the emergency room 
with disturbed consciousness and a seizure. She had 
no relevant medical history. She had been taking di-
etary supplements purchased via the internet for the 
proceeding week in order to lose weight. The supple-
ments contained caffeine and synephrine. The physi-
cal examination revealed a blood pressure of 115/84 
mmHg and pulse of 110 beats per minute. On auscul-
tation, the lungs were clear and heart sounds normal, 
with no murmur or gallop. The 12-lead electrocardio-
graph revealed sinus tachycardia, T wave inversion 
in leads II, III, aVF, and V3-6, and a prolonged QTc 
interval of 537 ms (Fig. 1). Laboratory analysis revealed 
creatine kinase (CK) 374 U/L (normal range, 21 to 215), 
CK-MB 9.9 ng/mL (normal range, < 4.3), troponin I 0.59 
ng/mL (normal range, < 0.07), brain natriuretic pep-
tide 734 pg/mL (normal range, < 100), and C-reactive 
protein 3.6 mg/L (normal range, 0.1 to 6.0). The serum 
catecholamine levels measured 3 days after admis-
sion showed dopamine 6.03 ng/mL (normal range, 0.5 
to 6.2), epinephrine 0.03 ng/mL (normal range, < 0.3), 
and norepinephrine 0.48 ng/mL (normal range, < 0.8). 
Transthoracic echocardiography (TTE) performed at 
the day of admission showed apical ballooning of the 
left ventricle due to akinesis from the apical to mid-
ventricular segments, and hyperkinesis of the basal 
segments, with a markedly reduced left ventricular 
ejection fraction of 28% (Fig. 2). The impairment ex-
tended across the coronary artery distribution. Car-
diac magnetic resonance (CMR) was performed 2 days 
after admission. The cine CMR findings were consis-
tent with TTE (Fig. 3A and 3B) and the late enhance-
ment CMR revealed no late gadolinium enhancement 
(Fig. 3C). In addition, reconstructed CMR images of 
the coronary arteries revealed no significant stenosis 
(Fig. 3D and 3E). Under a working diagnosis of ABS, 
she was treated conservatively with a β-blocker, angio-
tensin converting enzyme inhibitor, and loop diuret-
ics. Gradually, her symptoms improved. Another TTE 
performed 9 days after admission revealed a normal 
ejection fraction of 63%, with complete recovery of 
the apical and midventricular wall motion. While 
hospitalized, neurological evaluations including elec-
troencephalography and brain magnetic resonance 
imaging were performed to determine whether epi-
lepsy was the cause of her seizure. However, there was 
no definite evidence of epilepsy or other organic brain 
abnormalities. Therefore, she was not given any anti-
Figure 1. The 12-lead electrocardiograph on admission revealed sinus tachycardia, T wave inversion in leads II, III, aVF, and 
V3-6, and a prolonged QTc interval of 537 ms.
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epileptic medication. She remained stable clinically 
and hemodynamically for 10 days of hospitalization 
and was discharged home without cardiological or 
neurological sequelae. In the year since, there has been 
no recurrence of ABS or seizures.
DISCUSSION
Besides severe emotional or physical stress, drugs 
can precipitate ABS. However, the drugs reported to 
trigger ABS, such as dobutamine, epinephrine, and 
amphetamine, are either illegal or strictly controlled 
for medical use in many countries [5,6]. In contrast, 
this paper reports a case of ABS precipitated by dietary 
supplements that are freely available to the general 
public.
In 2004, the United States Food and Drug Admin-
istration determined that ephedra and ephedrine-
containing dietary supplements were unsafe for un-
regulated use and banned their sale. However, this ban 
does not preclude the use of other structurally related 
sympathomimetic amines in products for weight re-
duction. Consequently, synephrine has emerged as an 
alternative to ephedra in dietary supplements and is 
listed often as “extract of Citrus aurantium” or “extract 
of bitter orange.” Synephrine is a sympathomimetic 
amine derived from C. aurantium and shares structural 
similarities with other sympathomimetic phenyl-
ethylamine drugs, such as ephedrine, amphetamine, 
and phenylpropanolamine. Although synephrine is 
considered safe compared to ephedra, the toxicity of 
this substance is largely unknown, especially in com-
bination with caffeine, which potentiates the cardio-
vascular effects of other sympathomimetic agents. In 
addition, severe adverse cardiovascular side effects of 
synephrine-containing dietary supplements have been 
reported [7,8]. To our knowledge, this is the first report 
of ABS precipitated by synephrine-containing dietary 
supplements.
The pathophysiology of ABS remains poorly under-
stood. Several hypotheses have been proposed as the 
mechanisms of ABS, including direct catecholamine-
induced cardiomyocyte injury via intracellular calci-
um overload, and an indirect effect of a catecholamine 
surge resulting in epicardial spasm, microvascular 
dysfunction, or dynamic left ventricular outf low ob-
struction due to hyperkinesis of the basal segments [9]. 
Further studies are needed to clarify the pathophysi-
ological mechanism of ABS.
Figure 2. Apical four-chamber transthoracic echocardiography view during (A) diastole and (B) systole showing apical balloon-
ing of the left ventricle due to akinesis from the apical to midventricular segments, and hyperkinesis of the basal segments 
with a markedly reduced left ventricular ejection fraction of 28%.
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In conclusion, our case accentuates the potential 
risk of dietary supplements containing synephrine, 
a sympathomimetic similar to ephedra. Currently, 
the use of these dietary supplements is uncontrolled 
and they are freely available to the general public. The 
Korea Food and Drug Administration should take a 
stronger position regarding the regulation of these di-
etary supplements, and warn healthcare workers and 
the general public to be aware of the potential hazard 
of the indiscriminate abuse of dietary supplements.
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Figure 3. Cine cardiac magnetic resonance (CMR) images during (A) diastole and (B) systole were consistent with transthoracic 
echocardiography findings. (C) Late enhancement CMR revealed no late gadolinium enhancement. Reconstructed CMR image 
of the (D) right and (E) left coronary arteries revealed no significant stenosis.
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